FBTIX Mutual Fund

FBTIX Mutual Fund (Fidelity Advisor Biotechnology Fund Class I) is managed by Fidelity Investments (US) with $903.3M in net assets. FBTIX expense ratio is 0.71%, holding 92 positions across sectors including Health Care, Financials. Inception date: 2000-12-27.

FBTIX performance shows a YTD return of 21.71%. The 1-year return is 62.98% and the 5-year return is 12.91%. FBTIX dividend yield stands at 0.95%, paid annually.

FBTIX top holdings include Abbvie Inc. (16.6%), Gilead Sciences (6.6%), Alnylam Pharmaceuticals Inc. (5.0%), Ascendis Pharma A/S (4.5%), Cogent Biosciences Inc (3.8%). Go to all FBTIX holdings, FBTIX sectors, or FBTIX dividends.

FBTIX can be compared against other funds. Use FBTIX overlap to find shared positions, or FBTIX vs another fund for a side-by-side view. FBTIX alternatives are available via the screener, along with tax-loss harvesting opportunities.